Assessment of the Impact of Garlic in Heart-related Diseases

Victor Duniya SHENENI & Katumi Ohunene ENESI

1Department of Biochemistry, Faculty of Science, Federal University Lokoja, Nigeria

2Department of Biochemistry, Faculty of Natural Science, Prince Abubakar Audu University Anyigba, Nigeria

Full Text – HTML | PDF

Abstract

Atherosclerosis, hyperlipidemia, thrombosis, hypertension, and diabetes are just a few of the metabolic illnesses that garlic and its derivatives have been shown to prevent and treat. Experimental investigations on the effectiveness of garlic in heart-related disorders were more encouraging, which led to the initiation of multiple clinical trials. The effectiveness of garlic, particularly its cholesterol-lowering impact, has recently come under scrutiny despite the fact that numerous clinical investigations have demonstrated a favorable effect of garlic on practically all of the cardiovascular disorders listed above. As the least expensive method of preventing heart-related disease, using garlic properly and reaping its full benefits is a significant problem for scientists around the world. This review has made an effort to discuss the mechanisms of such therapeutic effects of garlic and to bridge the gap between experimental and clinical investigation.

Keywords

Garlic, Heart-related diseases, animal experiment, clinical trial

References

  1. Lawson LD: Garlic: a review of its medicinal effects and indicated active compounds. In: Phytomedicines of Europe. Chemistry and Biological Activity. Series 691 (Edited by: Lawson LD & Bauer R) American Chemical Society, Washington, DC 1998, 176-209
  2. Moyers S: Garlic in Health, History and World Cuisine. Suncoast Press, St. Petersburg, FL 1996, 1-36
  3. Woodward PW: Garlic and Friends: The History, Growth and Use of Edible Alliums Hyland House, Melbourne, Australia 1996, 2-22
  4. Rivlin RS: Patient with hyperlipidemia who received garlic supplements. Lipid management. Report from the Lipid Education Council 1998, 3:6-7
  5. Borek C: Antioxidant health effect of aged garlic extract. J Nutr 2001, 131:1010S-1015S
  6. Ryu K, Ide N, Matsuura H, Itakura Y: N alpha-(1-deoxy-D-fructos1-yl)-L-arginine, an antioxidant compound identified in aged garlic extract. J Nutr 2001, 131:972S-976S
  7. Schwartz CJ, Valente AJ, Sprague EA: A modern view of atherogenesis. Am J Cardiol 1993, 71:9b-14b
  8. Jain RC: Onion and garlic an experimental cholesterol atherosclerosis in rabbits. Artery 1975, 1:115-125
  9. Jain RC: Effect of garlic on serum lipids, coagulability and fibrinolytic activity of blood. Am J Clin Nutr 1977, 30:1380-1381
  10. Bordia A, Verma SK, Vyas AK, Khabya BL, Rathore AS, Bhu N, Bedi HK: Effect of essential oil of onion and garlic on experimental atherosclerosis in rabbits. Atherosclerosis 1977, 26:379-386
  11. Chang MLW, Johnson MA: Effect of garlic on carbohydrate metabolism and lipid synthesis in rats. J Nutr 1980, 110:931-936
  12. Kamanna VS, Chandrasekhara N: Hypocholesteromic activity of different fractions of garlic. Ind J Medical Res 1984, 79:580-583
  13. Mand JK, Gupta PP, Soni GL, Singh R: Effect of garlic on experimental atherosclerosis in rabbits. Ind Heart J 1985, 37:183-188
  14. Betz E, Weidler R: Die Wirkung von Knoblauchextrakt auf die atheerogenese bei kaninchen. In: Die anwendung aktueller methoden in der arteriosklerose. Forschung (Edited by: Betz E)1989, 304-311
  15. Rajasree CR, Rajmohan T, Agusti KT: Biochemical effects of garlic on lipid metabolism in alcohol fed rats. Ind J Exp Biol 1999, 37:243-247
  16. Mathew BC, Daniel RS: Hypolipidemic effect of garlic protein substituted for caseinin diet of rats compared to those of garlic oil. Ind J Exp Biol 1996, 34:337-340
  17. Qureshi AA, Din ZZ, Abuirameileh N, Burger WC, Ahmed Y, Elson CE: Suppression of avian hepatic lipid metabolism by solvent extracts of garlic: impact on serum lipids. J Nutr 1983, 113:1746-1755
  18. Kamanna VS, Chandrasekhara N: Effect of garlic on serum lipoproteins cholesterol levels in albino rats rendered hypercholesteremic by feeding cholesterol. Lipids 1982, 17:483-488
  19. Chi MS: Effect of garlic products on lipid metabolism in cholesterol-fed rats. Proc Soc Exp Biol Med 1982, 171:174-178
  20. Chi MS, Koh ET, Stewart TJ: Effect of garlic on lipid metabolism in rats fed cholesterol or lard. J Nutr 1982, 112:241-248
  21. Abramovitz D, Gavri S, Harats D, Levkovitz H, Mirelman D, Miron T, Eilat-Adar S, Rabinkov A, Wilchek M, Eldar M, Vered Z: Allicin-induced decrease in formation of fatty streaks (atherosclerosis) in mice fed a cholesterol-rich diet. Coron Artery Dis 1999, 10:515-519
  22. Efendy JL, Simmons DL, Campbell GR, Campbell JH: The effect of the aged garlic extract, ‘Kyolic’, on the development of experimental atherosclerosis. Atherosclerosis 1997, 132:37-42
  23. Campbell JH, Efendy JL, Smith NJ, Campbell GR: Molecular basis by which garlic suppresses atherosclerosis. J Nutr 2001, 131:1006S-1009S
  24. Lutomski J: Klinische Untersuchungen Zur therapeutischen wirksamkeit von llya Rogiff knoblanchpillen mit Rutin. Z Phytotherapia 1984, 5:938-942
  25. Luley C, Lehmann-Leo W, Moller B, Martin T, Schwartzkopff W: Lack of efficacy of dried garlic in patients with hyperlipoproteinemia. Arzneimittelforschung / Drug Res 1986, 36:766-768
  26. Ziaei S, Hantoshzadeh S, Rezasoltani P, Lamyian M: The effect of garlic tablet on plasma lipids and platelet aggregation in nulliparous pregnants at high risk of preeclampsia. Eur J Obstet Gynecol Reprod Biol 2001, 99:201-206
  27. Gardner CD, Chatterjee LM, Carlson JJ: The effect of a garlic preparation on plasma lipid levels in moderately hypercholesterolemic adults. Atherosclerosis 2001, 154:213-220
  28. Rahman K, Billington D: Dietary supplementation with aged garlic extract inhibits ADP-induced platelet aggregation in humans. J Nutr 2000, 130:2662-2665
  29. Superko HR, Krauss RM: Garlic powder, effect on plasma lipids, postprandial lipemia, low-density lipoprotein particle size, high-density lipoprotein subclass distribution and lipoprotein(a). J Am Coll Cardiol 2000, 35:321-326
  30. Byrne DJ, Neil HA, Vallance DT, Winder AF: A pilot study of garlic consumption shows no significant effect on markers of oxidation or sub-fraction composition of low-density lipoprotein including lipoprotein(a) after allowance for noncompliance and the placebo effect. Clin Chim Acta 1999, 285:2133
  31. McCrindle BW, Helden E, Conner WT: Garlic extract therapy in children with hypercholesterolemia. Arch Pediatr Adolesc Med 1998, 152:1089-1094
  32. Berthold HK, Sudhop T: Garlic preparations for prevention of atherosclerosis. Curr Opin Lipidol 1998, 9:565-569
  33. Isaacsohn JL, Moser M, Stein EA, Dudley K, Davey JA, Liskov E, Black HR: Garlic powder and plasma lipids and lipoproteins: a multicenter, randomized, placebo-controlled trial. Arch Intern Med 1998, 158:1189-1194
  34. Simons LA, Balasubramanian S: Von Konigsmark M, Parfitt A, Simons J, Peters W. On the effects of garlic on plasma lipids and lipoproteins in mild hypercholesterolemia. Atherosclerosis 1995, 113:219-225
  35. Silagy C, Neil A: Garlic as a lipid lowering agent-a meta-analysis. J R Coll Physician Lond 1994, 28:39-45
  36. Warshafsky S, Kamer RS, Sivak SL: Effect of garlic on total serum cholesterol, A meta-analysis. Ann Intern Med 1993, 119:599-605
  37. Neil HA, Silagy CA, Lancaster T, Hodgeman J, Vos K, Moore JW, Jones L, Cahill J, Fowler GH: Garlic powder in the treatment of moderate hyperlipidaemia: a controlled trial and meta-analysis. J R Coll Physicians Lond 1996, 30:329-334
  38. Stevinson C, Pittler MH, Ernst E: Garlic for treating hypercholesterolemia. A meta-analysis of randomized clinical trials. Ann Intern Med 2000, 133:420-429
  39. Orekhov AN, Grunwald J: Effects of garlic on atherosclerosis. Nutrition 1997, 13:656-663
  40. Yu-Yan Yeh, Liu L: Cholesterol lowering effect of garlic extracts and organosulfur compounds: Human and animal studies. J Nutr 2001, 131:989S-993S
  41. Munday JS, James KA, Fray LM, Kirkwood SW, Thompson KG: Daily supplementation with aged garlic extract, but not raw garlic, protects low density lipoprotein against in vitro oxidation. Atherosclerosis 1999, 143:399-404
  42. Lewin G, Popov I: Antioxidant effects of aqueous garlic extract. 2nd communication: Inhibition of the Cu(2+)-initiated oxidation of low density lipoproteins. Arzneimittelforschung 1994, 44:604-607
  43. Lau Benjamin HS: Suppression of LDL oxidation by garlic. J Nutr 2001, 131(3S):958S-988S
  44. Gebhardt R, Beck H: Differential inhibitory effects of garlic-derived organosulfur compounds on cholesterol biosynthesis in primary rat hepatocyte culture. Lipids 1996, 31:1269-1276
  45. Rodger B, Roberty B, Edward S: Fibrinolytic activity in acute myocardial infarction. Am J Clin Pathol 1972, 57:359-363
  46. Bordia A, Arora SK, Kothari LK, Jain KC, Rathore BS, Rathore AS, Dube MK, Bhu N: The protective action of essential oils of onion and garlic in cholesterol-fed rabbits. Atherosclerosis 1975, 22:103-109
  47. Sainani GS, Desai DB, Natu MN, Katrodia KM, Valame VP, Sainani PG: Onion, garlic, and experimental atherosclerosis. Jpn Heart J 1979, 20:351-357
  48. Mirhadi SA, Singh S, Gupta PP: Effect of garlic supplementation to cholesterol-rich diet on development of atherosclerosis in rabbits. Ind J Exp Biol 1991, 29:162-168
  49. Bordia AK, Joshi HK, Sandya YK, Bhu N: Effect of essential oil of garlic on serum fibrinalytic activity in patients with coronary artery disease. Atheroselerosis 1977, 28:155
  50. Bordia AK, Sodhya SK, Rathore AS, Bhu N: Essential oil of garlic on blood lipids and fibribolytic activity in patients with coronary artery disease. J Assoc Phys Ind 1978, 26:327-33
  51. Bordia AK, Sharma KD, Parmar VK, Varma SK: Protective effect of garlic oil on the changes produced by 3 weeks of fatty diet on serum cholesterol serum triglycerides, fibrimolytic acativity and platelet adhesiveness in man. Ind Heart J 1982, 34:86
  52. Chutani SK, Bardia A: The effect of fried versus Raw garlic on fibrinolytic activity in man. Atherosclerosis 1988, 38:417-421
  53. Sainani GS, Desai DB, Gorha NH, Natu SM, Pise DV, Sainani PG: Effect of dietary garlic and onion on serum lipid profile in Jain Community. Ind J of Med Res 1979, 69:776-780
  54. Arora RC, Arora S: Comparative effects of clofibrate, garlic and onion on alimentary hyperlipemia. Atherosclerosis 1981, 39:447-452
  55. Arora RC, Arora S, Gupta RK: The long-term use of garlic in ischemic heart disease. Atherosclerosis 1981, 40:175-179
  56. Legnani C, Frascaro M, Guazzaloca G, Ludovici S, Cesarano G, Coccheri S: Effects of a dried garlic preparation on fibrinolysis and platelet aggregation in healthy subjects. Arzneimittelforschung 1993, 43:119-122
  57. Bordia A, Verma SK, Srivastava KC: Effect of garlic (Allium sativum) on blood lipids, blood sugar, fibrinogen and fibrinolytic activity in patients with coronary artery disease. Prostaglandins Leukot Essent Fatty Acids 1998, 58:257-263
  58. Bordia AK, Joshi HK: Garlic on fibrinolytic activity in cases of acute myocardial infarction. J Assoc Physiol Ind 2978, 26:323-326
  59. Harfenist WJ, Murry RK, Murry RK, Mayes PA, Grannen DK, Rodwell VW: Plasma proteins, immunoglobulin and clotting factors.
  60. In: Harper’s Biochemistry (Edited by: Barnes DA) McGraw-Hill, New York, A Lange Medical Book 2000, 737-762
  61. Ali M, Thomson M, Alnaqeeb MA, al-Hassan JM, Khater SH, Gomes A: Antithrombotic activity of garlic: its inhibition of the synthesis of thromboxane-B2 during infusion of arachidonic acid and collagen in rabbits. Prostaglandins Leukot Essent Fatty Acids 1990, 41:95-99
  62. Srivastava KC: Effects of aqueous extracts of onion, garlic and ginger on platelet aggregation and metabolism of arachidonic acid in the blood vascular system: in vitro study. Prostaglandins Leukot Med 1984, 13:227-235
  63. Ali M: Mechanism by which garlic (Allium sativum) inhibits cyclooxygenase activity. Effect of raw versus boiled garlic extract on the synthesis of prostanoids. Prostaglandins Leukot Essent Fatty Acids 1995, 53:397-400
  64. Ali M, Bordia T, Mustafa T: Effect of raw versus boiled aqueous extract of garlic and onion on platelet aggregation. Prostaglandins Leukot Essent Fatty Acids 1999, 60:43-47
  65. Laurence WVD, John DF: Garlic extract prevents acute platelet thrombus formation in stenosed canine coronary arteries. Am Heart J 1989, 117:973-975
  66. Thomson M, Mustafa M, Ali M: Thromboxane-B(2) levels in serum of rabbits receiving a single intravenous dose of aqueous extract of garlic and onion. Prostaglandins Leukot Essent Fatty Acids 2000, 63:217-221
  67. el-Sabban F, Fahim MA, Radwan GM, Zaghloul SS, Singh S: Garlic preserves patency and delays hyperthermia-induced thrombosis in pial microcirculation. Int J Hyperthermia 1996, 12:513-525
  68. el-Sabban F, Radwan GM: Influence of garlic compared to aspirin on induced photothrombosis in mouse pial microvessels, in vivo. Thromb Res 1997, 88:193-203
  69. Apitz-Castro R, Escalante J, Vargas R, Jain MK: Ajoene, the antiplatelet principle of garlic, synergistically potentiates the antiaggregatory action of prostacyclin, forskolin, indomethacin and dypiridamole on human platelets. Thromb Res 1986, 42:303-311
  70. Apitz-Castro R, Badimon JJ, Badimon L: A garlic derivative, ajoene, inhibits platelet deposition on severely damaged vessel wall in an in vivo porcine experimental model. Thromb Res 1994, 75:243-249
  71. Apitz-Castro R, Badimon JJ, Badimon L: Effect of ajoene, the major antiplatelet compound from garlic, on platelet thrombus formation. Thromb Res 1992, 68:145-155
  72. Makheja AN, Bailey JM: Antiplatelet constituents of garlic and onion. Agents Actions 1990, 29:360-363
  73. Bordia A: Effect of garlic on human platelet aggregation in vitro. Atherosclerosis 1978, 30:355-360
  74. Vanderhock JY, Makheja AN, Bailey JM: Inhibition of fatty acid oxygenases by onion and garlic acts. Evidence for the mechanism by which these oils inhibit platelet aggregation. Biochem Pharmacol 1980, 29:3169-3173
  75. Apitz-Castro R, Cabrera S, Cruz MR, Ledezma E, Jain MK: Effects of garlic extract and of three pure components isolated from it on human platelet aggregation, arachidonate metabolism, release activity and platelet ultrastructure. Thromb Res 1983, 32:155-169
  76. Srivsatava KC: Evidence for the mechanism by which garlic inhibitors platelet aggregation. Prostaglandin Leukot Med 1986, 22:313-321
  77. Samson RR: Effects of dietary garlic and temporal drift on platelet aggregation. Atherosclerosis 1982, 44:119-120
  78. Harenberg J, Giese C, Zimmermann R: Effect of dried garlic on blood coagulation, fibrinolysis, platelet aggregation and serum cholesterol levels in patients with hyperlipoproteinemia. Atherosclerosis 1988, 74:247-249
  79. Kiesewetter H, Jung F, Pindur G, Jung EM, Mrowietz C, Wenzel E: Effect of garlic on thrombocyte aggregation, microcirculation, and other risk factors. Int J Clin Pharmacol Ther Toxicol 1991, 29:151-155
  80. Steiner M, Lin RS: Changes in platelet function and susceptibility of lipoproteins to oxidation associated with administration of aged garlic extract. J Cardiovasc Pharmacol 1998, 31:904-908
  81. Boullin DJ: Garlic as a platelet inhibitor. Lancet 1981, 1:776-777
  82. Wagner H, Wierer M, Fessler B: Effects of garlic constituents on arachidonate metabolism. Planta Med 1987, 53:305-306
  83. Srivastava KC, Tyagi OD: Effects of a garlic-derived principle (ajoene) on aggregation and arachidonic acid metabolism in human blood platelets. Prostaglandins Leukot Essent Fatty Acids 1993, 49:587-595
  84. Apitz-Castro R, Ledezma E, Escalante J, Jain MK: The molecular basis of the antiplatelet action of ajoene: direct interaction with the fibrinogen receptor. Biochem Biophys Res Commun 1986, 141:145-150
  85. Jamaluddin MP, Krishnan LK, Thomas A: Ajoene inhibition of platelet aggregation: possible mediation by a hemoprotein. Biochem Biophys Res Commun 1988, 153:479-486
  86. Ariga T, Oshiba S, Tamada T: Platelet aggregation inhibitor in garlic. Lancet 1981, 1:150-151
  87. Block E, Ahmad S, Jain MK, Crecely RW, Apitz Castro R, Cruz MR: (E,Z) Ajoene: A potent antithrombic agent from garlic. J Amer Chem Soc 1984, 106:8295-8296
  88. Kiesewetter H, Jung F, Jung EM, Mroweitz C, Koscielny J, Wenzel E: Effect of garlic on platelet aggregation in patients with increased risk of juvenile ischaemic attack. Eur J Clin Pharmacol 1993, 45:333-336
  89. Morris J, Burke V, Mori TA, Vandongen R, Beilin LJ: Effects of garlic extract on platelet aggregation: a randomized placebo-controlled double-blind study. Clin Exp Pharmacol Physiol 1995, 22:414-417
  90. Steiner M, Li W: Aged garlic extract, a modulator of cardiovascular risk factors: a dose-finding study on the effects of AGE on platelet functions. J Nutr 2001, 131(3s):980S-984S
  91. Schulz V, Hansel R, Tyler VE: Cardiovascular system. In: Rational Phytotherapy; physicians’ guide to herbal medicine Springer-verlag, Berlin 2001, 107-168
  92. Sial AY, Ahmed SJ: Study of the hypotensive action gerlic extract in experimental animals. J Pak Med Assoc 1982, 32:237-239
  93. Rashid A, Khan HH: The mechanism of hypotensive effect of garlic extract. J Pak Med Assoc 1985, 35:357-362
  94. Chanderkar AG, Jain PK: Analysis of hypotensive action of Allium sativum (garlic) Ind J Physiol Pharmacol 1973, 17:132-133
  95. Pantoja CV, Chiang Ch L, Norris BC, Concha JB: Diuretic, natriuretic and hypotensive effects produced by Allium sativum (garlic) in anaesthetized dogs. J Ethnopharmacol 1991, 31:325-331
  96. Banerjee AK: Effect of aqueous extract of garlic on arterial blood pressure of normotensive and hypertensive rats. Artery 1976, 2:369
  97. Ruffin J, Hunter SA: An evaluation of the side effects of garlic as an antihypertensive agent. Cytobias 1983, 37:85-89
  98. Foushee DB, Ruffin J, Banerjee U: Garlic as a natural agent for the treatment of hypertension: A preliminary report. Cytobios 1982, 34:145-152
  99. Malik ZA, Siddiqui S: Hypotensive effect of freeze-dried garlic (Allium sativum) sap in dog. J Pak Med Assoc 1981, 31:12-13
  100. Elkayam A, Mirelman D, Peleg E, Wilchek M, Miron T, Rabinkov A, Sadetzki S, Rosenthal T: The effects of allicin and enalapril in fructose-induced hyperinsulinemic hyperlipidemic hypertensive rats. Am J Hypertens 2001, 14:377-381
  101. Ali M, Al-Qattan KK, Al-Enezi F, Khanafer RM, Mustafa T: Effect of allicin from garlic powder on serum lipids and blood pressure in rats fed with a high cholesterol diet. Prostaglandins Leukot Essent Fatty Acids 2000, 62:253-259
  102. Kaye AD, De Witt BJ, Anwar M, Smith DE, Feng CJ, Kadowitz PJ, Nossaman BD: Analysis of responses of garlic derivatives in the pulmonary vascular bed of the rat. J Appl Physiol 2000, 89:353358
  103. Al-Qattan KK, Khan I, Alnaqeeb MA, Ali M: Thromboxane-B2, prostaglandin-E2 and hypertension in the rat 2-kidney 1-clip model: a possible mechanism of the garlic induced hypotension. Prostaglandins Leukot Essent Fatty Acids 2001, 64:5-10
  104. Kim-Park S, Ku DD: Garlic elicits a nitric oxide-dependent relaxation and inhibits hypoxic pulmonary vasoconstriction in rats. Clin Exp Pharmacol Physiol 2000, 27:780-786
  105. Fallon MB, Abrams GA, Abdel-Razek TT, Dai J, Chen SJ, Chen YF, Luo B, Oparil S, Ku DD: Garlic prevents hypoxic pulmonary hypertension in rats. Am J Physiol 1998, 275(2 Pt 1):L283-L287
  106. Brandle M, al Makdessi S, Weber RK, Dietz K, Jacob R: Prolongation of life span in hypertensive rats by dietary interventions.
  107. Effects of garlic and linseed oil. Basic Res Cardiol 1997, 92:223-232 106. Leoper M, DeBray M: Hypotensive effect of tincture of garlic. Prog Med 1921, 36:391-392
  108. Damru F: The use of garlic concentrate in vascular hypertension. Med Rec 1941, 153:249-251
  109. Piotrowski’ail en GL: therapeutique. Praxis 1948, 26:488-492
  110. Konig FK, Scineider B: Knoblauch bessert Durch-blutungstorungen Arztliche Praxis 1986, 38:44-35
  111. Auer W, Eiber A, Hertkom E, Kohrle U, Lenz A, Mader F, Merx W,Otto G, Schmid-Oto B, benheim H: Hypertonie and Hyperlipidamie: In leichterenauch Knoblauch. Der Allgemeinarzi 1989, 3:205-208
  112. Petkov V: Plants and hypotensive, antiatheromatous and coronarodilatating action: Am J Chin Med 1979, 7:197-236
  113. Zheziang Institute of Traditional Chinese Medicine: The effect of essential oil of garlic on hyperlipemia and platelet aggregation – an analysis of 308 cases. Cooperative Group for Essential Oil of Garlic. J Tradit Chin Med 1986, 6:117-120
  114. Silagy CA, Neil HA: A meta-analysis of the effect of garlic on blood pressure. J Hyperten 1994, 12:463-468
  115. Sendl A, Elbl G, Steinke B, Redl K, Breu W, Wagner H: Comparative pharmacological investigations of Allium ursinum and Allium sativum. Planta Medica 1992, 58:1-7
  116. Qidwai W, Qureshi R, Hasan SN, Azam SI: Effect of dietary garlic (Allium Sativum) on the blood pressure in humans – a pilot study. J Pak Med Assoc 2000, 50(6):204-207
  117. Steiner M, Khan AH, Holbert D, Lin RI: A double-blind crossover study in moderately hypercholesterolemic men that compared the effect of aged garlic extract and placebo administration on blood lipids. Am J Clin Nutr 1996, 64:866-870
  118. Jain AK, Vargas R, Gotzkowsky S, McMahon FG: Can garlic reduce levels of serum lipids? A controlled clinical study. Am J Med 1993, 94:632-635
  119. McMahon FG, Vargas R: Can garlic lower blood pressure? A pilot study. Pharmacotherapy 1993, 13:406-407
  120. Auer W, Eiber A, Hertkom E, Kohrle U, Lenz A, Mader F, Merx W,Otto G, Schmid-Oto B, benheim H: Hypertonie and Hyperlipidamie: In leichterenauch Knoblauch. Der Allgemeinarzi 1989, 3:205-208
  121. Zimmermann W, Zimmermann B: Reduction in elevated blood lipids in hospitalised patients by a standardised garlic preparation. Br J Clin Prac 1990, 44(suppl 69):20-23
  122. Vorberg G, Schneider B: Therapy with garlic: results of a placebo-controlled, double-blind study. Br J Clin Prac 1990, 44(suppl 69):7-11
  123. Granner DK, Murry RK, Mayes PA, Grannen DK, Rodwell VW: Hormones of the pancreas and gastrontestinal tract. In: Harper’s Biochemistry (Edited by: Barnes DA) McGraw-Hill, New York, A Lange Medical Book 2000, 610-626
  124. Ohaeri OC: Effect of garlic oil on the levels of various enzyme in the serum and tissue of streptozotocin diabtic rats. Biosci Rep 2001, 21:19-24
  125. Patumraj S, Tewit S, Amatyakul S, Jariyapongskul A, Maneesri S, Kasantikul V, Shepro D: Comparative effects of garlic and aspirin on diabetic cardiovascular complications. Drug Deliv 2000, 7:91-96
  126. Swanston-Flatt SK, Day C, Bailey CJ, Flatt PR: Traditional plant treatments for diabetes. Studies in normal and streptozotocin diabetic mice. Diabetologia 1990, 33:462-464
  127. Farva D, Goji LA, Joseph PK, Augusti KT: Effects of garlic oil on streptozotocin-diabetic rats maintained on normal and high fat diets. Indian J Biochem Biophys 1986, 23:24-27
  128. Kumar GR, Reddy KP: Reduced nociceptive responses in mice with alloxan induced hyperglycemia after garlic (Allium sastivum) teratment. Indian J Exp Biol 1999, 37:662-666
  129. Augusti KT, Sheela CG: Antiperoxide effect of S-allyl cysteine sulfoxide, a insulin secretagogue, in diabetic rats. Experientia 1996, 52:115-120
  130. Sheela CG, Kumud K, Augusti KT: Anti-diabetic effect of onion and garlic sulfoxide amino acids in rats. Planta Medica 1995, 61:356-357
  131. Sheela CG, Augusti KT: Antidiabetic effects of S-allyl cysteine sulphoxide isolated from garlic Allium sativum Linn. Indian J Exp Biol 1992, 30:523-526
  132. Jain RC, Vyas CR: Garlic in alloxan-induced diabetic rabbits. Am J Clin Nutr 1975, 28:684-685
  133. Mathew PT, Augusti KT: Studies on the effect of allicin (diallyl disulphide-oxide) on alloxan diabetes I. Hypoglycaemic action and enhancement of serum insulin effect and glycogen synthesis. Indian J Biochem Biophys 1973, 10:209-212
  134. Kasuga S, Ushijima M, Morihara N, Itakura Y, Nakata Y: Effect of aged garlic extract (AGE) on hyperglycemia induced by immobilization stress in mice. Nippon Yakurigaku Zassh 1999, 114:191-197
  135. Jain RC, Vyas CR: Hypoglycemic action of onion and garlic. Lancet 1973, 2:1491
  136. Zhang XH, Lowe D, Giles P, Fell S, Connock MJ, Maslin DJ: Gender may affect the action of garlic oil on plasma cholesterol and glucose levels of normal subjects. J Nutr 2001, 131:1471-1478
  137. Ali M, Thomson M: Consumption of garlic clove a day could be beneficial in preventing thrombosis. Prostaglandins Leukot Essent Fatty acids 1995, 53:211-212
  138. Li G, Shi Z, Jia H, Ju J, Wang X, Xia Z, Qin L, Ge C, Xu Y, Cheng L, Chen P, Yuan G: A clinical investigation on garlicin injectio for treatment of unstable angina pectoris and its actions on plasma endothelin and blood sugar levels. J Tradit Chin Med 2000, 20:243-246
  139. Rietz B, Belagyi J, Torok B, Jacob R: The radical scavenging ability of garlic examined in various models. Bolletino Chimico Farmaceutico 1995, 134:69-76
  140. Martin N, Bardisa L, Pantojaa C, Vargas M, Quezaada P, Valenzuela J: Antiarrhythmic profile of a gaarlic dialystate assaay ed in dogs and isolaated atrial preparations. J Ethanophrmacol 1994, 43:1-8
  141. Martin N, Bardisa L, Pantojaa C, Vargas M, Quezaada P, Valenzuela J: Antiarrhythmic profile of a gaarlic dialystate assaay ed in dogs and isolaated atrial preparations. J Ethanophrmacol 1994, 43:1-8
  142. Aqel MB, Gharaibah MN, Salhab AS: Direct relaxant effects of garlic juice on smooth and cardiac muscles. J Ethnopharmacol 1991, 33:13-19
  143. Tongia SK: Effects of intravenous garlic Juice Aallium sativum on rat Electrocardiogram. Ind J Physiol Pharmacol 1984, 28:250252
  144. Banerjee SK, Maulik M, Mancahanda SC, Dinda AK, Gupta SK, Maulik SK: Dose-dependent induction of endogenous antioxidants in rat heart by chronic administration of garlic. Life Scicences 2002, 70:1509-1518
  145. Banerjee SK, Maulik M, Manchanda SC, Dinda AK, Das TK, Maulik SK: Garlic-induced alteration in rat liver and kidney morphology and associated changes in endogenous antioxidant status. Food Chem Toxicol 2001, 39:793-797
  146. Imai J, Ide N, Nagae S, Moriguchi T, Matsuura H, Itakura Y: Antioxidant and radical scavenging effects of aged garlic extract and its constituents. Planta Med 1994, 60:417-420
  147. Geng Z, Lau B: Aged garlic extract modulates glutathione redox cycle and superoxide dismutase activity in vascular endothelial cells. Phytother Res 1997, 11:54-56
  148. Wei Z, Lau BHA: Garlic inhibits free radical generation and augments antioxidant enzyme activity in vascular endothelial cells. Nutr Res 1998, 18:61-70
  149. Banerjee SK, Maulik M, Gupta SK, Manchanda SC, Dinda AK, Maulik SK: Effect of chronic garlic intake on endogenous antioxidants and ischemic-reperfusion injury in isolated rat heart. Ind J Pharmacol 2001, 33:298
  150. Mukherjee S, Maulik M, Talwar KK, Dinda AK, Maulik SK: Effect of chronic raw garlic administration in adriamycin induced oxidant stress in rat hearts. Ind J Pharmacol 2001, 33:297
  151. Kojima R, Epstein CJ, Mizui T, Carlson E, Chaqn PH: Protective effects of aged garlic extracts on doxorubicin induced cardiotoxicity in the mouse. Nutr Cancer 1994, 22:163-173
  152. Ciplea AG, Richter KD: The protective effect of Allium sativum and crataegus on isoprenaline-induced tissue necrosis in rats. Arzneim-Forsch / Drug Res 1988, 38(II):1583-1592
  153. Isensee H, Rietz B, Jacob R: Cardioprotective action of garlic (Allium sativum). Arzneim Forsch / Drug Res 1993, 43:94-98
  154. Yamasaki T, Lau BH: Garlic compounds protect vascular endothelial cells from oxidant injury. Nippon Yakurigaku Zasshi 1997, 110(Suppl 1):138P-141P
  155. Breithaupt-Grogler K, Belz GG: Epidemiology of the arterial stiffness. Pathol Biol (Paris) 1999, 47:604-613
  156. Breithaupt-Grogler K, Ling M, Boudoulas H, Belz GG: Protective effect of chronic garlic intake on elastic properties of aorta in the elderly. Circulation 1997, 96:2649-2655
  157. Kiesewetter H, Jung F, Mrowietz C, Pindur G, Heiden M, Wenzel E, Gu LD: Effects of garlic on blood fluidity and fibrinolytic activity: a randomised, placebo-controlled, double-blind study. Br J Clin Pract 1990, 69:24-29
  158. Jung EM, Jung F, Mrowietz C, Kiesewetter H, Pindur G, Wenzel E: Influence of garlic powder on cutaneous microcirculation. A randomized placebo-controlled double-blind cross-over study in apparently healthy subjects. Arzneimittelforschung 1991, 41:626-630
  159. Das T, Roychoudhury A, Sharma A, Talukder G: Effects of crude garlic extract on mouse chromosomes in vivo. Food and Chemical Toxicology 1996, 34:43-47
  160. Augusti KT: Therapeutic values of onion (Allium cepa L) and garlic (Allium sativum L). Ind J Exp Biol 1996, 34:634-640
  161. Nakagawa S, Masamoto K, Sumiyoshi H, Kunihiro K, Fuwa T: Effect of raw and extracted aged garlic on growth of young rats and their organ after peroral administration. J Toxicol Sci 1980, 5:91112
  162. Joseph PK, Rao KR, Sundaresh CS: Toxic effects of garlic extract and garlic oil in rats. Ind J Exp Biol 1989, 27:977-979
  163. Chen L, Hong JY, So E, Hussain AH, Cheng WF: Decrease of hepatic catalase level by treatment with diallyl sulfide and garlic homogenates in rats and mice. J Biochem Mol Toxicol 1999, 13:127-133
  164. Augusti KT, Mathew PT: Effect of allicin on certain enzymes of liver after a short-term feeding to normal rats. Experentia 1975, 31:148-149
  165. Dixit VP, Joshi S: Effects of chronic administration of garlic (Allium sativum Linn) on testicular function. Ind J Exp Biol 1982, 20:534-536
  166. Egen-Schwind C, Eckard R, Kemper FH: Metabolism of garlic constituents in the isolated perfused rat liver. Planta Medica 1992, 58:301-305
  167. Sheen LY, Li CK, Sheu SF, Meng RHC, Tsai SJ: Effect of the active principle of garlic-diallyl sulfide- on cell viability, detoxification capability and the antioxidation system on primary rat hepatocytes. Food Chem Toxicol 1996, 34:971-978
  168. Sheen LY, Chen HW, Kung YL, Liu CT, Lii CK: Effects of garlic oil and its organosulfur compounds on the activities of hepatic drug-metabolizing and antioxidant enzymes in rats fed highand low-fat diets. Nutr Cancer 1999, 35:160-166
  169. Gallwitz H, Bonse S, Martinez-Cruz A, Schlichting I, Schumacher K, Krauth-Siege RL: Ajoene is an inhibitor and subversive substrate of human glutathione reductase and Trypanosoma cruzi trypanothione reductase: crystallographic, kinetic, and spectroscopic studies. J Med Chem 1999, 42:364-372
  170. Rabinkov A, Miron T, Mirelman D, Wilchek M, Glozman S, Yavin E, Weiner L: S-Allylmercaptoglutathione: the reaction product of allicin with glutathione possesses SH-modifying and antioxidant properties. Biochim Biophys Acta 2000, 1499:144-153
  171. Beck E, Grunwald J: Allium sativum in der Stufentherapie der Hyperlipidamie. Med Welt 1993, 44:516-520
  172. Koch HP, Hahn G, Lawson L, Reuter HD, Siegers CP: Garlic-An introduction to the therapeutic application of Allium sativum L. Williams & Wilkins, Baltimore, im Druck 1995
  173. Eming SA, Piontek JO, Hunzelmann N, Rasokat H, Scharffetter-Kachanek K: Severe toxic contact dematitis caused by garlic. Br J Dermatol 1999, 141:391-392
  174. Falleroni AE, Zeiss CR, Levitz D: Occupational asthma secondary to inhalation of garlic dust. J Allergy Clin Immunol 1981, 68:156-160
  175. Papageogiou D, Corbet JP, Menezes F-Brando, Pecegueiro M, Benezra C: Allergic: contact dermatitis to garlic (Allium sativum I) identification of the allergens: the role of mono-, di- and trisulfides present in garlic. Arch Dermatol Res 1983, 275:229-234
  176. Rose KD, Croissant PD, Parliament CF, Levin MB: Spontaneous Spinal Epidural Hematoma with Associated Platelet Dysfunction from Excessive Garlic Ingestion: A case Report. Neurosurgery 1990, 26:880-882
  177. Sunter WH: Warfarin and garlic. Pharm J 1991, 246:722
  178. Burnham BE: Garlic as a possible risk for postoperative bleeding. Plast Recon Surg 1995, 95:213
  179. Fugh-Berman A: Herb-drug interactions. Lancet 2000, 355:134138
  180. Petry JJ: Garlic and postoperative bleeding. Plastic Recon Surg 1995, 96:483-484
  181. Kendler BS: Garlic (Allium sativum) and onion (Allium cepa): a review of their relationship to cardiovascular disease. Prev Med 1987, 16(5):670-685
  182. Keys A: Wine, garlic and CHD in seven countries. Lancet 1980, 1(8160):145-146
Assessment of the Impact of Garlic in Heart-related Diseases